Page 3 - Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 23, 2024

Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

85 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

RGS

Regeneus
AU$0.013160.0%8.3%AU$1.5mn/aPS4xn/an/a

ANR

Anatara Lifesciences
AU$0.0580%107.1%AU$11.2mn/aPB8.2xn/an/a

TYP

Tryptamine Therapeutics
AU$0.045-8.2%n/aAU$57.4mn/aPS43.3xn/an/a

VLS

Vita Life Sciences
AU$2.080.5%20.6%AU$117.1mn/aPE12.5xn/a4.3%

AGH

Althea Group Holdings
AU$0.038-9.5%-2.6%AU$19.3mn/aPB61.5xn/an/a

OSL

OncoSil Medical
AU$0.007-12.5%-22.2%AU$31.4mn/aPS20.1xn/an/a

FRE

Firebrick Pharma
AU$0.053-7.0%-17.2%AU$11.1mn/aPS4xn/an/a

AVE

Avecho Biotechnology
AU$0.002-33.3%-50.0%AU$6.3mn/aPS18.7xn/an/a

VTL

VGI Health Technology
AU$0.020%n/aAU$2.8mn/aPS112.4xn/an/a

BTG

Beroni Group
AU$0.990%n/aAU$75.9mn/aPS39.8xn/an/a

WFL

Wellfully
AU$0.0030%-87.0%AU$1.5mn/aPE-0.2xn/an/a

TRP

Tissue Repair
AU$0.262.0%6.1%AU$15.7mn/aPS8.8xn/an/a

IDT

IDT Australia
AU$0.10-4.8%7.5%AU$43.0mn/aPS3.1xn/an/a

VIT

Vitura Health
AU$0.0984.3%-68.9%AU$57.0mn/aPE16.2xn/a0%

NUZ

Neurizon Therapeutics
AU$0.19-5.0%131.7%AU$92.5mn/aPS109.8xS58.2%n/a

NSB

NeuroScientific Biopharmaceuticals
AU$0.0372.8%-47.9%AU$5.4mn/aPE16.5xn/an/a

RGT

Argent BioPharma
AU$0.25-12.3%-64.5%AU$13.6mn/aPS15.2xn/an/a

ATX

Amplia Therapeutics
AU$0.088-10.2%10.0%AU$24.2mn/aPS5.4xn/an/a

EMD

Emyria
AU$0.03914.7%-47.3%AU$16.2mn/aPS7.4xn/an/a

OCC

Orthocell
AU$0.61-1.6%51.9%AU$147.1mn/aPS27.7xn/an/a

VBS

Vectus Biosystems
AU$0.080%-74.6%AU$4.3mn/aPS3.7xn/an/a

CHM

Chimeric Therapeutics
AU$0.009-10.0%-71.0%AU$8.1mn/aPS1.1xn/an/a

SPL

Starpharma Holdings
AU$0.129.5%-17.9%AU$48.0mn/aPS4.9xn/an/a

CTE

Cryosite
AU$0.901.7%38.8%AU$43.7mn/aPE23.7xn/a2.2%
Page 3 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.